Universe Pharmaceuticals INC

NasdaqCM:UPC Rapport sur les actions

Capitalisation boursière : US$3.0m

Universe Pharmaceuticals Bilan de santé

Santé financière contrôle des critères 3/6

Universe Pharmaceuticals possède un total de capitaux propres de $26.7M et une dette totale de $6.5M, ce qui porte son ratio d'endettement à 24.3%. Son actif total et son passif total sont $49.4M et de $22.7M.

Informations clés

24.3%

Ratio d'endettement

US$6.51m

Dette

Ratio de couverture des intérêtsn/a
Argent liquideUS$11.39m
Fonds propresUS$26.74m
Total du passifUS$22.69m
Total des actifsUS$49.43m

Mises à jour récentes de la santé financière

Recent updates

Universe Pharmaceuticals INC (NASDAQ:UPC) Not Doing Enough For Some Investors As Its Shares Slump 44%

Nov 14
Universe Pharmaceuticals INC (NASDAQ:UPC) Not Doing Enough For Some Investors As Its Shares Slump 44%

Why Investors Shouldn't Be Surprised By Universe Pharmaceuticals INC's (NASDAQ:UPC) 92% Share Price Plunge

Sep 27
Why Investors Shouldn't Be Surprised By Universe Pharmaceuticals INC's (NASDAQ:UPC) 92% Share Price Plunge

Universe Pharmaceuticals INC's (NASDAQ:UPC) 41% Price Boost Is Out Of Tune With Revenues

Jul 22
Universe Pharmaceuticals INC's (NASDAQ:UPC) 41% Price Boost Is Out Of Tune With Revenues

Universe Pharmaceuticals INC's (NASDAQ:UPC) Price Is Right But Growth Is Lacking After Shares Rocket 31%

May 22
Universe Pharmaceuticals INC's (NASDAQ:UPC) Price Is Right But Growth Is Lacking After Shares Rocket 31%

Universe Pharmaceuticals INC's (NASDAQ:UPC) Shares Bounce 27% But Its Business Still Trails The Industry

Apr 07
Universe Pharmaceuticals INC's (NASDAQ:UPC) Shares Bounce 27% But Its Business Still Trails The Industry

Investors Don't See Light At End Of Universe Pharmaceuticals INC's (NASDAQ:UPC) Tunnel And Push Stock Down 27%

Feb 07
Investors Don't See Light At End Of Universe Pharmaceuticals INC's (NASDAQ:UPC) Tunnel And Push Stock Down 27%

There's No Escaping Universe Pharmaceuticals INC's (NASDAQ:UPC) Muted Revenues Despite A 54% Share Price Rise

Dec 18
There's No Escaping Universe Pharmaceuticals INC's (NASDAQ:UPC) Muted Revenues Despite A 54% Share Price Rise

Universe pharmaceuticals receives Nasdaq notification regarding minimum bid price deficiency

Jul 19

Improved Earnings Required Before Universe Pharmaceuticals INC (NASDAQ:UPC) Shares Find Their Feet

Feb 21
Improved Earnings Required Before Universe Pharmaceuticals INC (NASDAQ:UPC) Shares Find Their Feet

We Think That There Are Some Issues For Universe Pharmaceuticals (NASDAQ:UPC) Beyond Its Promising Earnings

Aug 10
We Think That There Are Some Issues For Universe Pharmaceuticals (NASDAQ:UPC) Beyond Its Promising Earnings

Analyse de la situation financière

Passif à court terme: Les actifs à court terme de UPC ( $33.5M ) dépassent ses passifs à court terme ( $20.6M ).

Passif à long terme: Les actifs à court terme de UPC ( $33.5M ) dépassent ses passifs à long terme ( $2.1M ).


Historique et analyse du ratio d'endettement

Niveau d'endettement: UPC dispose de plus de liquidités que de sa dette totale.

Réduire la dette: Le ratio d'endettement de UPC est passé de 23.3% à 24.3% au cours des 5 dernières années.

Couverture de la dette: Le flux de trésorerie opérationnel de UPC est négatif, par conséquent la dette n'est pas bien couverte.

Couverture des intérêts: Données insuffisantes pour déterminer si les paiements d'intérêts de UPC sur sa dette sont bien couverts par l'EBIT.


Bilan


Découvrir des entreprises saines